• Molecule Produced by Parasitic Worms Could Lead to New Asthma Therapies, Study Suggests
  • Vitamin D Supplements Reduce Asthma Flare-ups, Study Shows
  • FDA Giving Priority Review to Gilotriftm as Treatment for Rare Form of Lung Cancer
  • New Blocker of TGF-β1 Shows Promise as Potential Therapy for IPF Patients
  • Pulmonary Rehabilitation Improves Patients’ Ability to Exercise and Quality of Life, Study Reports
  • Opdivo, Alone or Combined with Yervoy, Extends Lung Cancer Patients’ Survival, Phase 1/2 Trial Shows
  • Pulmonary Fibrosis Foundation’s Awareness Walk Raises Over $230K for Research
  • Vibativ Displays More Punch Against Bacteria Than Other Antibiotics, Studies Show
  • Potential Oral Asthma Therapy Enters Phase 1 Clinical Development, OncoArendi Says
  • Duke Undergrads to Do Medical Research, Including Developing Tool to Spot CF Infections
  • Bacteria-derived Factor R1R2 Has Potential as Antifibrotic Medication, Mouse Study Suggests
  • FDA Opens the Door for People with Asthma to Use Antifungal Therapy Pulmazole

Pulmonary Fibrosis

Asthma

Bronchiectasis

BRONCHIOLITIS

CHRONIC BRONCHITIS

COPD

 CYSTIC FIBROSIS

EMPHYSEMA

IDIOPATHIC PULMONARY FIBROSIS

LUNG CANCER

PNEUMONIA

PULMONARY HYPERTENSION

SCLERODERMA